0001209191-23-058990.txt : 20231218
0001209191-23-058990.hdr.sgml : 20231218
20231218171226
ACCESSION NUMBER: 0001209191-23-058990
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trizzino John
CENTRAL INDEX KEY: 0001468534
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 231494681
MAIL ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-14
0
0001000694
NOVAVAX INC
NVAX
0001468534
Trizzino John
C/O NOVAVAX, INC.
700 QUINCE ORCHARD ROAD
GAITHERSBURG
MD
20878
0
1
0
0
EVP, CCO and CBO
0
Common Stock
2023-12-14
4
M
0
1600
A
11428
D
Common Stock
2023-12-14
4
F
0
773
5.69
D
10655
D
Restricted Stock Units
2023-12-14
4
M
0
1600
0.00
D
Common Stock
1600
0
D
The restricted stock units ("RSU"s) subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date.
The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs.
Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
/s/ Mark Casey, Attorney-in-Fact
2023-12-18